We have over 15 years of experience

  • +(962) 6 5512561/2 , +(971) 569498820

  • contact@sipsmena.com

  • 8:30am - 5:30pm

  • Sunday to Thursday

Pharmaceutical Patents Search


Pharmaceutical Patents Search, Reading and Analysis

(29th & 30th October 2002).


Seminar themes

  1. Statistical analysis of the last 20 years of patent.
  2. The special search program of the EPO-DG1:
  3. The content of the program.
  4. Why use the European Patent office.
  5. What EPO offers.
  6. Different search types.



Dr. Andreas Winkler

Dr. H. Meylaerts

Dr. Heinz Goddar

Dr. Karachalios & Dr. Mohammed Saleem. 



Due to queries regarding confusion between our seminar “Pharmaceutical Patent Search, Reading and Analysis” and our previous seminar “Patents for Product Choice”, please note that our speakers have reviewed in the latter seminar two products namely Fexofenadine and Amlodepine.  The review focused on the patent picture of the molecule to be manufactured into finished product.  Patent restrictions were shown in order to enable participants the knowledge of requesting “non infringing” process of manufacturer, formulation and final dosage form.


In this seminar “Pharmaceutical Patent Search, Reading and Analysis” we take a step back and provide how we reached the patent picture of one example molecule namely fexofenadine. We will demonstrate:


§  Techniques used by the EPO for freedom-to-act search;


§  Subsequently, we will take all patents and relate each patent to the intended marketable product;


§  Further more, reading one patent thoroughly to understand the reached interpretation of infringement; and


§  Putting all infringing acts from the basic new chemical entity patent to patents of medical use and modified dosage forms.


This seminar allows participants the ability to conduct and conclude near freedom-to-act search and conclusions. The attached chart explains the link between the two seminars. The shaded boxes distinguish the present seminar under the title “Pharmaceutical Patent Search, Reading and Analysis” from the previous seminar under the title “Patents for Product Choice”.